Waylan Bessler - Concepedia

Author

Waylan Bessler

Indiana University – Purdue University Indianapolis ORCID

Also Known As

Angus, Steven P, Angus, Steven P., Stuhlmiller, Timothy J, W. K. Bessler, Waylan Bessler, Waylan K Bessler, Waylan K. Bessler

302

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Indiana University – Purdue University Indianapolis Indiana University School of Medicine Fox Chase Cancer Center University of North Carolina at Chapel Hill Indiana University Health

About

Waylan Bessler is an author at Indiana University – Purdue University Indianapolis specializing in medicine, cell biology, and neuro-oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	852
2	Cell Biology	4	4	740
3	Neurology	2	2	112
4	Health Sciences	1	1	523
5	Neuroscience	1	1	27

Waylan Bessler

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors Jamie Case, Laura E. Mead, Waylan Bessler, Experimental Hematology Human Cd34+ac133+vegfr-2+ CellsEndothelial Progenitor CellsDevelopmental BiologyAngiogenesisLymphocyte Development	2007	523
p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics Jayme D. Allen, Zahara M. Jaffer, Su-Jung Park, Blood	2009	119
Endothelial Colony Forming Cells and Mesenchymal Stem Cells are Enriched at Different Gestational Ages in Human Umbilical Cord Blood Munaza Javed, Laura E. Mead, Daniel N. Prater, Pediatric Research Regenerative MedicineMesenchymal Stem CellsDevelopmental BiologyMedicineAdult Stem Cell	2008	103
Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation Steven D. Rhodes, Yongzheng He, Abbi E. Smith, Human Molecular Genetics Neuro-oncologyPlexiform NeurofibromaGliomaMedicineMalignant Transformation	2019	90
Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial Michael J. Fisher, Chie‐Schin Shih, Steven D. Rhodes, Nature Medicine Neuro-oncologyFibrosisPlexiform NeurofibromasNeurofibromatosis Type 1–RelatedPathology	2021	85
Genetic and cellular evidence of vascular inflammation in neurofibromin-deficient mice and humans Elisabeth A. Lasater, Fang Li, Waylan Bessler, Journal of Clinical Investigation	2010	79
Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/− mast cells Andrew S. McDaniel, Jayme D. Allen, Su-Jung Park, Blood	2008	79
Nf1+/- mice have increased neointima formation via hyperactivation of a Gleevec sensitive molecular pathway Elisabeth A. Lasater, Waylan Bessler, Laura E. Mead, Human Molecular Genetics	2008	59
Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK Long‐Sheng Chang, Janet L. Oblinger, Abbi E. Smith, PLoS ONE	2021	49
<i>K-ras</i> Is Critical for Modulating Multiple c-kit-Mediated Cellular Functions in Wild-Type and <i>Nf1</i> +/− Mast Cells Waleed Khalaf, Feng‐Chun Yang, Shi Chen, The Journal of Immunology	2007	39

Page 1